Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK4 | P11802 | 6/20 | 0.44 |
| ▸ | CCND1 | P24385 | 6/20 | 0.44 |
| ▸ | CCND2 | P30279 | 6/20 | 0.44 |
| ▸ | CCND3 | P30281 | 6/20 | 0.44 |
| ▸ | CCNB2 | O95067 | 3/20 | 0.44 |
| ▸ | CCNE2 | O96020 | 3/20 | 0.44 |
| ▸ | CDK1 | P06493 | 3/20 | 0.44 |
| ▸ | FGFR1 | P11362 | 3/20 | 0.44 |
| ▸ | CCNB1 | P14635 | 3/20 | 0.44 |
| ▸ | CCNA2 | P20248 | 3/20 | 0.44 |
| ▸ | FGFR2 | P21802 | 3/20 | 0.44 |
| ▸ | FGFR4 | P22455 | 3/20 | 0.44 |
| ▸ | FGFR3 | P22607 | 3/20 | 0.44 |
| ▸ | CCNE1 | P24864 | 3/20 | 0.44 |
| ▸ | CDK2 | P24941 | 3/20 | 0.44 |
| ▸ | CCNA1 | P78396 | 3/20 | 0.44 |
| ▸ | CCNB3 | Q8WWL7 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 7/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.40 |
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21925 | 0.85 | USP2 (0.47) | TSHRLMNAMAPK1USP2MEN1 | |
| SCHEMBL8406727 | 0.84 | USP2 (0.46) | TSHRLMNAMAPK1USP2MEN1 | |
| SCHEMBL8406726 | 0.83 | USP2 (0.45) | TSHRLMNAMAPK1USP2MEN1 | |
| SCHEMBL5712394 | 0.78 | MTNR1A (0.40) | TSHRLMNAUSP2ALDH1A1SMN1; SMN2 | |
| SCHEMBL5712356 | 0.78 | MAPK1 (0.45) | TSHRLMNAMAPK1USP2MEN1 | |
| SCHEMBL5712361 | 0.74 | ADORA2B (0.40) | TSHRMAPK1ALDH1A1SMN1; SMN2 | |
| SCHEMBL5712352 | 0.74 | PARG (0.42) | TSHRLMNAMAPK1USP2MEN1 | |
| SCHEMBL5712364 | 0.74 | ALDH1A1 (0.59) | TSHRLMNAMAPK1USP2MEN1 | |
| SCHEMBL8422870 | 0.74 | USP2 (0.44) | TSHRLMNAMAPK1USP2ALDH1A1 | |
| SCHEMBL8423120 | 0.74 | USP2 (0.46) | TSHRLMNAMAPK1USP2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140179518-A1 | Pesticidal Mixtures Comprising Cyanosulfoximine Compounds | BASF SE (DE) | 2014-06-26 | — | — | US | claimed |
| JP-2012500824-A | — | — | 2012-01-12 | — | — | JP | claimed |
| JP-2011527306-A | — | — | 2011-10-27 | — | — | JP | claimed |
| US-20110159107-A1 | Pesticidal Mixtures Comprising Isoxazoline Compounds II | BASF SE (DE) | 2011-06-30 | — | — | US | claimed |
| US-20110160054-A1 | Pesticidal Mixtures Comprising Cyanosulfoximine Compounds and Spinetoram | BASF SE (DE) | 2011-06-30 | — | — | US | claimed |
| EP-2320741-A2 | PESTICIDAL MIXTURES COMPRISING CYANOSULFOXIMINE COMPOUNDS AND SPINETORAM | BASF SE (DE) | 2011-05-18 | — | — | EP | claimed |
| EP-2317856-A1 | PESTICIDAL MIXTURES COMPRISING ISOXAZOLINE COMPOUNDS II | BASF SE (DE) | 2011-05-11 | — | — | EP | claimed |
| US-20110105321-A1 | Pesticidal Mixtures Comprising Cyanosulfoximine Compounds | BASF SE (DE) | 2011-05-05 | — | — | US | claimed |
| EP-2219456-A1 | PESTICIDAL MIXTURES COMPRISING CYANOSULFOXIMINE COMPOUNDS | BASF SE (DE) | 2010-08-25 | — | — | EP | claimed |
| WO-2010023171-A2 | PESTICIDAL MIXTURES COMPRISING CYANOSULFOXIMINE COMPOUNDS AND SPINETORAM | BASF SE (DE) | 2010-03-04 | — | — | WO | claimed |
| WO-2010003877-A1 | PESTICIDAL MIXTURES COMPRISING ISOXAZOLINE COMPOUNDS II | BASF SE (DE) | 2010-01-14 | — | — | WO | claimed |
| WO-2009062905-A1 | PESTICIDAL MIXTURES COMPRISING CYANOSULFOXIMINE COMPOUNDS | BASF SE (DE) | 2009-05-22 | — | — | WO | claimed |
| WO-2009007233-A2 | PESTICIDAL MIXTURES COMPRISING SULFONAMIDES AND ONE OR MORE FUNGICIDES | BASF SE (DE) | 2009-01-15 | — | — | WO | claimed |
| US-20140179518-A1 | Pesticidal Mixtures Comprising Cyanosulfoximine Compounds | BASF SE (DE) | 2014-06-26 | — | — | US | disclosed |
| US-8597688-B2 | Pesticidal mixtures comprising isoxazoline compounds II | BASF SE (DE) | 2013-12-03 | — | — | US | disclosed |
| US-20110160054-A1 | Pesticidal Mixtures Comprising Cyanosulfoximine Compounds and Spinetoram | BASF SE (DE) | 2011-06-30 | — | — | US | disclosed |
| WO-2010023171-A2 | PESTICIDAL MIXTURES COMPRISING CYANOSULFOXIMINE COMPOUNDS AND SPINETORAM | BASF SE (DE) | 2010-03-04 | — | — | WO | disclosed |
| WO-2010003877-A1 | PESTICIDAL MIXTURES COMPRISING ISOXAZOLINE COMPOUNDS II | BASF SE (DE) | 2010-01-14 | — | — | WO | disclosed |
| WO-2009062905-A1 | PESTICIDAL MIXTURES COMPRISING CYANOSULFOXIMINE COMPOUNDS | BASF SE (DE) | 2009-05-22 | — | — | WO | disclosed |
| WO-2009007233-A2 | PESTICIDAL MIXTURES COMPRISING SULFONAMIDES AND ONE OR MORE FUNGICIDES | BASF SE (DE) | 2009-01-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110159107-A1 | Pesticidal Mixtures Comprising Isoxazoline Compounds II | PRDX1, PRDX2, PRDX5 | CDK4 1233/4885CCND1 1016/4885CCND2 388/4885 |
| US-20140179518-A1 | Pesticidal Mixtures Comprising Cyanosulfoximine Compounds | CPN1, SRM, STS | CDK4 1303/4885CCND1 203/4885CCND2 87/4885 |
| US-20110105321-A1 | Pesticidal Mixtures Comprising Cyanosulfoximine Compounds | CPN1, SRM, STS | CDK4 1303/4885CCND1 203/4885CCND2 87/4885 |
| US-20110160054-A1 | Pesticidal Mixtures Comprising Cyanosulfoximine Compounds and Spinetoram | CHRM3, CHRM2, BRS3 | CDK4 3923/4885CCND1 4357/4885CCND2 4516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.